Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
European Urology Oncology
|
November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216
Umang Swami, Yeonjung Jo, Arshit Narang, et al.
JAMA Network Open
|
March 20, 2025
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Yeonjung Jo, Gliceida Galarza Fortuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer
Nicolas Sayegh, Ryon P Graf, Umang Swami, et al.
Cancer
|
April 2, 2024
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, et al.
JAMA Network Open
|
April 7, 2026
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States
Chadi Hage Chehade, Zeynep Irem Ozay, Yeonjung Jo, et al.
JAMA Network Open
|
October 2, 2025
Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations
Micah Ostrowski, Yeonjung Jo, Chadi Hage Chehade, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
European Urology Oncology
|
November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216
Umang Swami, Yeonjung Jo, Arshit Narang, et al.
JAMA Network Open
|
March 20, 2025
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Yeonjung Jo, Gliceida Galarza Fortuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer
Nicolas Sayegh, Ryon P Graf, Umang Swami, et al.
Cancer
|
April 2, 2024
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, et al.
JAMA Network Open
|
April 7, 2026
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States
Chadi Hage Chehade, Zeynep Irem Ozay, Yeonjung Jo, et al.
JAMA Network Open
|
October 2, 2025
Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations
Micah Ostrowski, Yeonjung Jo, Chadi Hage Chehade, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Page
of 3